Miller Arlo J, Levy Carmit, Davis Ian J, Razin Ehud, Fisher David E
Dana-Farber Cancer Institute and Children's Hospital, Department of Pediatric Hematology/Oncology, Melanoma Program in Medical Oncology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 2005 Jan 7;280(1):146-55. doi: 10.1074/jbc.M411757200. Epub 2004 Oct 25.
MITF and its related family members TFE3 and TFEB heterodimerize with each other, recognize the same DNA sequences, and are subject to many of the same post-translational modifications. We show that lysine residues within conserved small ubiquitin-like modifier (SUMO) consensus sites in these family members are subject to SUMO modification. Mutation of these sites significantly affects the transcriptional activity of MITF but does not alter dimerization, DNA binding, stability, or nuclear localization. Mutagenesis reducing the number of MITF binding sites in the promoter of TRPM1 from three to one eliminated the difference in transcriptional activity between the MITF mutants. Among other MITF target gene promoter constructs, differences in transcriptional activity between wild type and non-sumoylatable MITF were only seen in promoters with multiple MITF binding sites. These data support a synergy control model in which the functional consequences of MITF sumoylation depend on promoter context. Sumoylation, thus, provides a possible mechanism for altering the effects of MITF by affecting the target genes that it activates.
MITF及其相关家族成员TFE3和TFEB相互异源二聚化,识别相同的DNA序列,并受到许多相同的翻译后修饰。我们发现这些家族成员中保守的类泛素小修饰物(SUMO)共有位点内的赖氨酸残基会发生SUMO修饰。这些位点的突变显著影响MITF的转录活性,但不改变二聚化、DNA结合、稳定性或核定位。将TRPM1启动子中MITF结合位点的数量从三个减少到一个的诱变消除了MITF突变体之间转录活性的差异。在其他MITF靶基因启动子构建体中,野生型和不可SUMO化的MITF之间转录活性的差异仅在具有多个MITF结合位点的启动子中可见。这些数据支持一种协同控制模型,其中MITF SUMO化的功能后果取决于启动子背景。因此,SUMO化提供了一种可能的机制,通过影响MITF激活的靶基因来改变其作用效果。